Toxicity of β‐amyloid vaccination in patients with Alzheimer's disease
2002; Wiley; Volume: 51; Issue: 6 Linguagem: Inglês
10.1002/ana.10218
ISSN1531-8249
Autores Tópico(s)Prion Diseases and Protein Misfolding
ResumoAnnals of NeurologyVolume 51, Issue 6 p. 794-794 Letters Toxicity of β-amyloid vaccination in patients with Alzheimer's disease Bruno Pietro Imbimbo PhD, Bruno Pietro Imbimbo PhD Chiesi Farmaceutici, Parma, ItalySearch for more papers by this author Bruno Pietro Imbimbo PhD, Bruno Pietro Imbimbo PhD Chiesi Farmaceutici, Parma, ItalySearch for more papers by this author First published: 21 May 2002 https://doi.org/10.1002/ana.10218Citations: 15Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Schenk D, Barbour R, Dunn W, et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 1999; 400: 173– 177. 2 Poduslo JF, Curran GL. Amyloid beta peptide as a vaccine for Alzheimer's disease involves receptor-mediated transport at the blood–brain barrier. NeuroReport 2001; 12: 3197– 3200. 3 Bard F, Cannon C, Barbour R, et al. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 2000; 6: 916– 919. 4 Grubeck-Loebenstein B, Blasko I, Marx FK, Trieb I. Immunization with beta-amyloid: could T-cell activation have a harmful effect? Trends Neurosci 2000; 23: 114. 5 Marx F, Blasko I, Zisterer K, Grubeck-Loebenstein B. Transfected human B cells: a new model to study the functional and immunostimulatory consequences of APP production. Exp Gerontol 1999; 34: 783– 795. Citing Literature Volume51, Issue6June 2002Pages 794-794 ReferencesRelatedInformation
Referência(s)